Linfomas asociados a la infección por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 113, Issue 9, 1999, Pages 349-356

  Ribera, Josep M ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; B CELL LYMPHOMA; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PATHOLOGY;

ADULT; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED;

EID: 0033603981     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Ziegler JL, Beckstead JA, Volkberding PA et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 565-570.
2. Centers for Disease Control. Revision of the CDC surveillance definition for acquired immunodeficiency syndrome. MMWR 1987; 36: 1.
3. CDC 1992 revised classification system for human immunodeficiency virus infection and expanded AIDS surveillance case definition for adolescents and adults. Draft, November 15, 1991. CDC. Public Health Service Atlanta (Georgia): US Department of Health and Human Services, 1991.
4. Serraino D, Salamina G, Franceschi S, Dubois D, La Vecchia C, Brunet JB et al. The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the Worlh Health Organization European Region. Br J Cancer 1992; 66: 911-916.
5. Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 1994; 86: 1.711-1.716.
6. Johnson CC, Wilcosky T, Kvale P, Rosen P, Stansell J, Glassroth J et al. Cancer incidence among an HIV-infected cohort. Pulmonary Complications of HIV Study Group. Am J Epidemiol 1997; 146: 470-475.
7. Granovsky MO, Mueller BU, Nicholson HS, Rosenberg PS, Rabkin CS. Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute. J Clin Oncol 1998; 16: 1.729-1.735.
8. Muñoz A, Schrager LK, Bacellar H, Speizer Y, Vermund SH, Detels R et al. Trends in the incidence of outcomes defining AIDS in the multicenter AIDS-Cohort Study Group 1985-1991. Am J Epidemiol 1993; 137: 423-438.
9. Armenian HK, Hoover DR, Rubb S, Metz S, Martínez-Maza O, Chmiel J et al. Risk factors for non-Hodgkin's lymphomas in acquired immunodeficiency syndrome (AIDS). Am J Epidemiol 1996; 143: 374-379.
10. Lacoste D. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. Cancer 1998; 82: 996-998.
11. Jones SL, Hanson DL, Ward JW. Effect of antiretroviral therapy on recent trends in cancers among HIV-infected persons. Second National AIDS Malignancy Conference. Bethesda 1998 [resumen]. J AIDS Hum Retrovirol 1998; 17: 38.
12. Rabkin C, Testa MA, Fischl MA, von Roenn J. Declining incidence of Kaposi's sarcoma in AIDS Clinical Trial Groups. Second national AIDS Malignancy Conference. Bethesda 1998 [resumen]. J AIDS Hum Retrovirol 1998 17: 39.
13. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino ChJ, Holmberg SD. Increased incidence of Hodgkin's disease in homosexual men with HIV infection. Ann Intern Med 1992; 117: 309-311.
14. Gaidano G, Carbone A, Dalla-Favera R. Pathogenesis of AIDS-related lymphomas. Am J Pathol 1998; 152: 623-630.
15. Strauss DJ. Human immunodeficiency virus-associated lymphomas. Med Clin North Am 1997; 81: 495-510.
16. Knowles DM. Molecular pathology of acquired immunodeficiency-related non-Hodgkin's lymphomas. Semin Diagn Pathol 1997; 14: 67-82.
17. Przybylski GK, Goldman G, Ng VL. Evidence for early B-cell activation preceeding the development of Epstein-Barr virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood 1996; 88: 4.620-4.629.
18. Cesarman E, Chang Y, Moore PS, Said JW Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-cased lymphomas. N Engl J Med 1995; 332: 1.186-1.191.
19. Gaidano G, Carbone A, Pastore C, Capello D, Migliazza A, Gloghini A et al. Frequent mutations of the 5' noncoding region of the bcl-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1997; 89: 3.755-3.762.
20. Sandler AS, Kaplan LD. Diagnosis and management of systemic non-Hodgkin's lymphoma in HIV disease. Hematol Oncol Clin North Am 1996; 10: 1.111-1.123.
21. Tirelli U, Spina M, Vaccher E, Errante D, Tavio M, Simonelli C et al. Clinical evaluation of 451 patients with HIV related non-Hodgkin's lymphoma: experience of the Italian Cooperative Group on AIDS and Tumors (GICAT). Leuk Lymphoma 1995; 20: 91.
22. Pintado V, López-Dupla JM, Valencia ME, Lavilla P, Martin A, González MD et al. Neoplasias asocidas a la infección por el virus de la inmunodeficiencia humana. Estudio clínico y evolutivo de 70 pacientes. Med Clin (Barc) 1993; 100: 730-735.
23. Ribera JM, Navarro JT, Oriol A, Raventos A, Sirera G, Flores A et al. Linfomas no hodgkinianos en pacientes con infección por el virus de la inmunodeficiencia humana. Caracteristicas clinicopatológicas, respuesta al tratamiento y pronóstico en 40 pacientes. Sangre (Barc) 1994; 39: 429-434.
24. Rubio R, Pulido V, Pintado J, Diaz-Mediavilla J, Flores E, Serrano M et al. Linfomas no hodgkinianos asociados al síndrome de inmunodeficiencia adquirida. Estudio clínico multicéntrico de 77 casos. Med Clin (Barc) 1995; 104: 481-486.
25. Ribas A, Bellmunt J, Albanell J, Capdevila JA, Ocaña I, Gallego OS et al. Malignant lymphoproliferative diseases in HIV-seropositive patients. A study of 40 patients at a single institution in Spain. Acta Oncologica 1995; 34: 75-82.
26. th Conference of Retroviruses and Opportunistic Infections [resumen]. Chicago, 1999.
27. Carbone A, Gaidano G. HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity. Br J Haematol 1997; 97: 515-522.
28. F Cobo, E Montserrat, E Campo. Linfoma primario de cavidades. Una nueva entidad clinicopatológica. Med Clin (Barc) 1997; 109: 712-714.
29. Hsi ED, Foreman KE, Duggan J, Alkan S, Kauffman CA, Aronow HD et al. Molecular and pathologic characterization of an AIDS-realted body cavity-based lymphoma, including ultrastructural demosntration of human herpesvirus-8: a case report. Am J Surg Pathol 1998; 22: 493-499.
30. Oksenhendler E, Clauvel JP, Juoveshomme S, Davi F, Mansour G. Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol 1998; 57: 266.
31. Camilleri-Broet S, Davi F, Feuillard J, Seilhean D, Michiels JF, Brousset P et al. AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-associated Tumors. Hum Pathol 1997; 28: 367-374.
32. D Vela, JM Ribera, R Florensa, Arellano A, Vaquera M, Batlle M et al. Compresión medular en los linfomas no hodgkinianos. Estudio de diez pacientes. Med Clin (Barc) 1997; 109: 375-377.
33. R Rubio, M Rubio, F Graus. Primary central nervous sytem lymphoma (PCNSL) in AIDS. A multicentric clinical study. XI International Conference on AIDS. Vancouver, 1996; 291.
34. Raphael M, Gentilhomme O, Tulliez M, Byron PA, Diebold J, for the French Study Group of Pathology for Human Immunodeficiency Virus-associated Tumours. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991; 115: 15-20.
35. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised european-american classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1.361-1.392.
36. González-Clemente JM, Ribera JM, Campo E, Bosch X, Montserrat E, Grau JM. Ki-1 anaplastic lymphoma of T-cell origin in an HIV-infected patient. AIDS 1991; 5: 751-755.
37. Tirelli U, Vaccher E, Zagonel V, Talamini R, Bernardi D, Tavio M et al. CD30 (Ki-1) anaplastic large cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection; the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol 1995; 13: 373-380.
38. Rubio R, for the Cooperative Study Group of Malignancies Associated with HIV infection in Madrid. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 patients. Cancer 1994; 73: 2.400-2.407.
39. Carbone A, Gaidano G, Gloghini A, Larocca LM, Capello D, Canzonieri V et al. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 1998; 91: 747-755.
40. J Romeu, M Fraile, P de las Heras, O García. Valor del SPECT cerebral con Talio-210 para el diagnostico del linfoma cerebral primario en el sida. Med Clin (Barc) 1995; 105: 275.
41. th World AIDS Conference [resumen]. Ginebra 1998.
42. Cingolani A, De Luca A, Larocca LM, Ammassari A, Scerrati M, Antinori A et al. Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst 1998; 90: 364-369.
43. Levine AM, Sullivan-Halley J, Pike MC. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 1991; 68: 2.466-2.472.
44. Oriol A, Ribera JM, López-Guillermo A, Feliu E. Factores pronósticos en los linfomas no hodgkinianos en pacientes con infección por el virus de la inmunodeficiencia humana. Med Clin (Barc) 1993; 102: 118-119.
45. Vaccher E, Tirelli U, Spina M, Talamini R, Errante D, Simonelli C et al. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients. J Clin Oncol 1996; 14: 2.217-2.223.
46. The International non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for agressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
47. Navarro JT, Ribera JM, Vaquera M, Vaquera M, Romeu J, Batlle M et al. International Prognostic Index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's Lymphoma treated with CHOP. A multivariate study of 46 patients. Haematologica 1998; 83: 508-513.
48. Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features od 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995; 13: 1.758-1.767.
49. Gill P, Levine A, Krnilo M. AIDS-related malignant lymphoma. Results of prospective treatment trials. J Clin Oncol 1987; 5: 1.319-1.328.
50. Walsh C, Wernz JC, Levine A, Rarick M, Willson E, Melendez D et al. Phase-I trial of M-BACOD and granulocyte-macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr 1993; 6: 265-271.
51. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseses and AIDS Clinical Trials Group. N Engl J Med 1997; 1.641-1.648.
52. Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L et al. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy. J Natl Cancer Inst 1997; 89: 301-307.
53. Tosi P, Gherlinzoni F, Mazza P, Visani G, Coronado O, Costigliola P et al. 3′-azido 3′ deoxythimidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomas. Blood 1997; 89: 419-425.
54. JT Navarro, JM Ribera, J Gómez-Espuch, E Feliu. Efecto del G-CSF después de la quimioterapia con CHOP en pacientes con linfoma no hodgkiniano infectados por el VIH. Med Clin (Barc) 1996; 107: 119-120.
55. Tirelli U, Errante D, Spina M, Vaccher E, Serraino D, Boiocchi M et al. Long-term survival in patients with HIV-related systemic non-Hodgkin's lymphoma. Hematol Oncol 1996; 14: 7-15.
56. Spina M, Tirelli U, Zagonel V, Gloghini A, Volpe R, Babare R et al. Burkill's lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients. Cancer 1998; 82: 766-774.
57. Tan B, Ratner L. The use of new antiretroviral therapy in combination with chemotherapy. Curr Opin Oncol 1997; 9: 455-464.
58. Corn BW, Trock BJ, Curran WJ. Management of primary central nervous system lymphoma for the patient with acquired immunodeficiency syndrome. Cancer 1995; 76: 163-166.
59. Jacomet C, Girard PM, Lebrette MG, Faresse VL, Monfort L, Rozenbaum W. Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS. AIDS 1997; 11: 1.725-1.730.
60. Scadden DT, Doweiko J, Schenkein D. A phase I/II trial of combined immunoconjugate and chemotherapy for AIDS-related lymphoma. Blood 1993; 82: 386.
61. Emilie D, Wijdenes J, Gisselbrecht Ch, Jarrousse B, Billaud E, Blay JY et al. Administration of anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B symptoms. Blood 1994; 84: 2.472-2.479.
62. nd National AIDS Malignancy Conference [resumen]. Bethesda, 1998.
63. Gabarre J. Leblond V, Sulton L, Tubiana R, Bastion Y, Schlaifer D et al. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma. Bone Marrow Transplant 1996; 18: 1.195-1.197.
64. Neal TF, Holland K, Baum CM, Villinger F, Ansari AA, Saral R et al. CD34+ progenitor cells from assymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 1995; 86; 1.749-1.756.
65. Curiel TJ, Piché Akasano K, Curiel DT. Gene therapy for AIDS-related malignancies. Gene Ther 1997; 4: 1.284-1.288.